Dive into Venture Series – Part I

Arc Ventures is proud to present the Dive into Ventures series. This regular video series features engaging conversations about the future of venture capital. For our first episode, we're leading a conversation between Early Stage Venture funds and Corporate Venture funds. We discuss their different investment strategies, what they look for in companies, and what…

ChargePoint, Inc. to Become Public Company

Arc portfolio company ChargePoint announced that it will become a public company through a business combination with Switchback Energy Acquisition Corporation (NYSE:SBE), valued at $2.4 Billion. The official press release can be found here. ChargePoint, Inc. to Become Public Company, Advancing EV Charging Network’s Reach Across North America and Europe Business Combination with Switchback Energy…

PolyPid Ltd. Announces Closing of Initial Public Offering

PolyPid successfully completed its initial public offering on the NASDAQ, June 30th 2020. Arc Ventures first invested in the company in 2016. You can find more information about the investment here. PolyPid's original press release can be found on its website. PolyPid Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option…

Facebook buys GIF website Giphy to integrate with Instagram

Giphy is a portfolio company of Arc Ventures' portfolio fund Betaworks. (from Reuters) - Facebook Inc is acquiring Giphy, a popular website for making and sharing animated images, or GIFs, Facebook said in a blog post on Friday. From Reuters: FILE PHOTO: A 3D printed Facebook logo is placed between small toy people figures in…

Ayala Pharmaceuticals Announces Closing of Initial Public Offering

Ayala is an Arc Ventures portfolio company since 2018 . The official press release can be found on the company's website. REHOVOT, Israel & WILMINGTON, Del., May 12, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and…

Vayyar Imaging Announces $109 Million Series D Financing led by Koch Disruptive Technologies

Vayyar Imaging today announced it closed a $109 million Series D financing round led by Koch Disruptive Technologies (Koch), with Regal Four and all existing investors including Battery Ventures, Bessemer Ventures, ICV, ITI, WRVI Capital, Claltech, bringing the total capital raised to-date to $188 million USD.